Filing Flows › Codexis (CDXS) › Q2 2026 › vs Q2 2025
Codexis (CDXS) Q2 2026 vs Q2 2025 (year over year)
Codexis's revenue fell $413K (-3%) from $15.3M in Q2 2025 to $14.9M in Q2 2026. The biggest changes: Research and development revenue −$6.3M (-79%); Product revenue +$5.8M (+79%).
Codexis, Q2 2026: revenue $14.9M (-3% year over year), operating margin -75.3%, net loss $12.0M, operating cash flow −$9.6M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product revenue | $13.2M | $7.4M | $5.8M | +79% |
| Research and development revenue | $1.7M | $7.9M | −$6.3M | -79% |
| Revenue | $14.9M | $15.3M | −$413K | -3% |
| Net loss | $12.0M | $13.3M | −$1.3M | -10% |
| Costs & expenses | $26.9M | $28.6M | −$1.7M | -6% |
| Operating costs | $26.1M | $28.2M | −$2.0M | -7% |
| Interest & other, net | $766K | $400K | $366K | +92% |
| Income tax | $10K | $10K | $0 | 0% |
| Cost of revenue | $3.5M | $2.1M | $1.4M | +67% |
| Research & development | $11.7M | $13.8M | −$2.1M | -15% |
| SG&A | $10.9M | $12.3M | −$1.4M | -11% |
| Operating cash sources | $12.4M | $21.8M | −$9.4M | -43% |
| Depreciation & amortization | $1.2M | $1.3M | −$130K | -10% |
| Share-based compensation | $1.6M | $2.5M | −$949K | -37% |
| Cash used in operations | $9.6M | $18.0M | −$8.3M | -46% |
| Net loss absorbed | $12.0M | $13.3M | −$1.3M | -10% |
| Working capital & other | $431K | $8.6M | −$8.1M | -95% |
Questions
How much did Codexis's revenue grow year over year in Q2 2026?
Codexis's revenue fell $413K (-3%) from $15.3M in Q2 2025 to $14.9M in Q2 2026.
What drove Codexis's revenue change in Q2 2026?
Research and development revenue −$6.3M (-79%); Product revenue +$5.8M (+79%).